Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Chongqing Zhifei Biological Products Co.,Ltd.    300122   CNE100000V20

CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.

(300122)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
07/28/2020 07/29/2020 07/30/2020 07/31/2020 08/03/2020 Date
160.5 176.55 182.03 186 190.1 Last
27262390 18010160 38050990 31614450 35414300 Volume
-0.96% +10.00% +3.10% +2.18% +2.20% Change
Financials
Sales 2020 15 110 M 2 165 M 2 165 M
Net income 2020 3 346 M 479 M 479 M
Net Debt 2020 1 206 M 173 M 173 M
P/E ratio 2020 90,8x
Yield 2020 0,43%
Sales 2021 18 401 M 2 636 M 2 636 M
Net income 2021 4 225 M 605 M 605 M
Net Debt 2021 1 275 M 183 M 183 M
P/E ratio 2021 73,1x
Yield 2021 0,48%
Capitalization 304 B 43 571 M 43 576 M
EV / Sales 2020 20,2x
EV / Sales 2021 16,6x
Nbr of Employees 2 972
Free-Float 14,7%
More Financials
Company
Chongqing Zhifei Biological Products Co., Ltd. is a China-based company principally engaged in the research, development, production, sale and distribution of vaccine products. The Company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevision and treatment of tuberculosis, viral vaccines for the prevention of rabies virus,... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
Surperformance© ratings of Chongqing Zhifei Biologica
Trading Rating : Investor Rating :
More Ratings
Latest news on CHONGQING ZHIFEI BIOLOGICA
07/30CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : half-yearly earnings release
07/09CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : China's Zhifei starts Phase II trial of C..
RE
06/23CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Chinese firm gets approval to begin human..
RE
04/16CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : annual earnings release
02/26NEW CHINESE BILLIONAIRES OUTPACE U.S : Hurun
RE
More news
News in other languages on CHONGQING ZHIFEI BIOLOGICA
07/30CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : half-yearly earnings release
07/30CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Veröffentlichung des Halbjahresergebnisse..
07/30CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : publication des résultats semestriels
07/09CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : China's Zhifei starts Phase II trial of C..
06/23CHONGQING ZHIFEI BIOLOGICAL PRODUCTS : Chinese firm gets approval to begin human..
More news
Chart CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.
Duration : Period :
Chongqing Zhifei Biological Products Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHONGQING ZHIFEI BIOLOGICA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 131,11 CNY
Last Close Price 190,10 CNY
Spread / Highest target 6,92%
Spread / Average Target -31,0%
Spread / Lowest Target -52,6%
EPS Revisions
Managers
NameTitle
Ren Sheng Jiang Chairman & General Manager
Yu Qin Wu Chairman-Supervisory Board
Zhen Jing Li Chief Financial Officer & Director
Yu Feng Chen Vice Chairman & Deputy General Manager
Ling Feng Jiang Director & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.282.80%42 666
CSL LIMITED0.50%87 881
BIOGEN INC.-7.43%43 487
SAMSUNG BIOLOGICS CO.,LTD.69.98%40 657
WUXI BIOLOGICS (CAYMAN) INC.64.01%27 951
UCB53.53%24 353